Where are healthcare costs rising — and where are providers finding savings?
Healthcare organizations are finding meaningful savings opportunities across clinical products and pharmaceuticals. But in many areas, price increases continue to outpace those gains.
The numbers tell a story of continued cost pressure.
The 2026 Curvo Pricing Trends Report analyzes billions in healthcare purchasing activity to uncover where costs are rising, where savings are emerging, and what’s driving the difference across clinical supplies, GPO pharmaceuticals and 340B pharmaceuticals.
Clinical products
$93.8M
in savings
$134.8M
in price increases
GPO pharmaceuticals
$32.3M
in savings
$61.7M
in price increases
340B pharmaceuticals
$58.6M
in savings
$124.6M
in price increases
Inside the report
See what’s driving the movement.
Download the full report for a deeper look at:
Clinical product categories driving the greatest savings and price increases
Manufacturers with the most significant pricing movement
Where savings opportunities are emerging across clinical supply spend
How pricing dynamics differ across GPO and 340B pharmaceuticals
How competition, biosimilars and specialty drugs are shaping pharmaceutical costs
Get instant access
Get the full 2026 Curvo Pricing Trends Report to explore the data.
